Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Net Margin Growth (1y) (2013 - 2026)

Analysis

Iqvia Holdings (IQV) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -113.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 220.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -413.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -515.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 5,083.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -7,766.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 53.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.07 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -752,733.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -113.00
Mar 31, 2026 -36.00
Dec 31, 2025 4.00
Sep 30, 2025 81.00
Jun 30, 2025 -282.00
Mar 31, 2025 -94.00
Dec 31, 2024 -137.00
Sep 30, 2024 -69.00
Jun 30, 2024 158.00
Mar 31, 2024 -18.00
Dec 31, 2023 621.00
Sep 30, 2023 -17.00
Jun 30, 2023 63.00
Mar 31, 2023 -125.00
Dec 31, 2022 -265.00
Sep 30, 2022 44.00
Jun 30, 2022 220.00
Mar 31, 2022 297.00
Dec 31, 2021 475.00
Sep 30, 2021 393.00